Abstract: Systems, methods, and software of performing a UE challenge. In one embodiment, User Equipment (UE) initiates a UE challenge procedure to a home network before engaging in a primary authentication procedure by generating a UE challenge by encrypting a random nonce with a home network public key, and transmitting a first message containing the UE challenge toward the home network. The UE receives a second message containing a challenge response to the UE challenge, processes the challenge response to determine whether the home network decrypted the random nonce in response to the UE challenge, and verifies an identity of the home network when the home network decrypted the random nonce in response to the UE challenge.

Abstract: A device and method for intravascular treatment of atherosclerotic plaque prior to balloon angioplasty which microperforates the plaque with small sharp spikes acting as serrations for forming cleavage lines or planes in the plaque. The spikes may also be used to transport medication into the plaque. The plaque preparation treatment enables subsequent angioplasty to be performed at low balloon pressures of about 4 atmospheres or less, reduces dissections, and avoids injury to the arterial wall. The subsequent angioplasty may be performed with a drug-eluting balloon (DEB) or drug-coated balloon (DCB). The pre-angioplasty perforation procedure enables more drug to be absorbed during DEB or DCB angioplasty, and makes the need for a stent less likely. Alternatively, any local incidence of plaque dissection after balloon angioplasty may be treated by applying a thin, ring-shaped tack at the dissection site only, rather than applying a stent over the overall plaque site.

Abstract: A fast charging system for electrically driven vehicles and a method for forming an electrically conductive connection between a vehicle and a stationary charging station, the fast charging system having a contact device, a charging contact device and a positioning device, said contact device or said charging contact device being disposeable on a vehicle, said charging contact device being electrically contacted using the contact device when in a contact position, said contact device being positioned in a longitudinal and/or transverse direction with respect to the charging contact device as well as being moved to the contact position by means of the positioning device, said charging contact device comprising a charging-contact-element carrier having charging contact elements, said charging contact elements each forming a strip-shaped charging contact surface, said contact device comprising a contact element carrier having contact elements, said contact elements each forming a contact surface which is smaller

Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.

Abstract: Authentication in a public land mobile network, PLMN, having tenant slices is performed by a network element that has: a memory comprising program code; a communication circuitry for communication with entities in the PLMN; and a processing circuitry configured to execute the program code and according to the program code to cause: detecting a registration request from a mobile communication device, MCDt; detecting whether the registration request requests access to a network slice with one-tier authentication with the network slice, and: if yes, causing beginning of authenticating the MCDt with the network slice independently of any authentication between the MCDt and the PLMN.

Abstract: The apparatus includes at least one processor; and at least one memory storing instructions that, when executed by the at least one processor, cause the apparatus at least to duplicate base station computation of an identifier value for a user equipment, and search for one or more control channel transmissions incorporating an identifier value matching the identifier value.

Abstract: Systems and methods can involve wedge dissectors attached to strips in turn attached to medical balloons, for forming serrations within vascular wall tissue for angioplasty as well as drug delivery.

Abstract: A device and method for intravascular treatment of atherosclerotic plaque prior to balloon angioplasty which microperforates the plaque with small sharp spikes acting as serrations for forming cleavage lines or planes in the plaque. The spikes may also be used to transport medication into the plaque. The plaque preparation treatment enables subsequent angioplasty to be performed at low balloon pressures of about 4 atmospheres or less, reduces dissections, and avoids injury to the arterial wall. The subsequent angioplasty may be performed with a drug-eluting balloon (DEB) or drug-coated balloon (DCB). The pre-angioplasty perforation procedure enables more drug to be absorbed during DEB or DCB angioplasty, and makes the need for a stent less likely. Alternatively, any local incidence of plaque dissection after balloon angioplasty may be treated by applying a thin, ring-shaped tack at the dissection site only, rather than applying a stent over the overall plaque site.

Abstract: A method for programming an implantable medical device for stimulating a human or animal heart with the help of a programming device. The method comprises the following steps: a) providing a first input parameter to the programming device, the first input parameter being indicative whether a first stimulation unit is to be used to stimulate the His bundle of a heart; b) if the first input parameter indicates that the first stimulation unit is to be used to stimulate the His bundle of the heart, supporting a user of the programming device to configure the implantable medical device for His bundle pacing by automatically proposing at least one stimulation parameter and an assigned stimulation parameter value specifically adapted for His bundle pacing; c) allowing programming of the implantable medical device by allowing setting the at least one stimulation parameter value.

Abstract: A programming device for programming an implantable medical device for stimulating a human or animal heart, wherein the programming device carries out the steps: a) allowing to select one of at least two electrode lead configurations for stimulating a heart, wherein the at least two electrode lead configurations comprise: i) a first electrode lead in which an atrial electrode lead and a right ventricular electrode lead are connected to electrode lead ports, and ii) a second electrode lead in which an atrial electrode lead and a His bundle electrode lead are connected to electrode lead ports; b) allowing to select a first timing parameter value if the first electrode lead is selected and to select a second timing parameter value if the second electrode lead is selected, wherein the first timing parameter value is an atrioventricular interval and the second timing parameter value is an atrial-His interval.

Abstract: An implantable medical device for stimulating a human or animal heart. In operation, the device performs the following steps: a) sensing an atrial electric signal a the first detection unit; b) sensing an electric signal at the His bundle with a second detection unit upon termination of a first time period starting upon sensing the atrial electric signal with the first detection unit and/or starting upon applying a stimulation pulse, wherein the first time period lies in a range of from 10 ms to 100 ms; c) classifying the electric signal sensed with the second detection unit as His bundle activity signal or as ventricular activity signal.

Abstract: An implantable medical device for stimulating a human/animal heart, comprising a first electrode lead port for receiving an electrode lead. The first electrode lead port comprises a first marking element and a second marking element, wherein the first marking element indicates a first kind of electrode lead that can be received by the first electrode lead port and for an operation of which the first electrode lead port is designed to be configured, wherein the first kind of electrode lead is a His bundle electrode lead , wherein the second marking element indicates a second kind of electrode lead that can be received by the first electrode lead port and for an operation of which the first electrode lead port is designed to be configured. The second kind of electrode lead includes one of an atrial electrode lead, a right ventricular electrode lead, and a left ventricular electrode lead.

Abstract: An implantable medical device for stimulating a human/animal heart having a stimulation unit which stimulates the His bundle and a detection unit which detects an electrical signal at the His bundle. The device performs: a) determining a first value of a parameter of a first measuring pulse measured between a first electrode pole and a housing; b) determining a second value of the same parameter of a second measuring pulse measured between the first electrode pole and a second electrode pole; c) comparing the first and second values; d) determining, based on the comparing step, whether the first or second measuring pulses enables a higher available level control range of the analog-to-digital converter; e) measuring an impedance in a unipolar manner between the first electrode pole and the housing or in a bipolar manner between the first electrode pole and the second electrode pole depending on the determining step.

Abstract: A programming device for programming an implantable medical device for stimulating a human or animal heart, wherein the following steps are performed: a) allowing to select one of at least two electrode lead configurations for stimulating a human or animal heart, wherein the at least two electrode lead configurations comprise a second electrode lead configuration in which at least one electrode lead is connected to an electrode lead port, the electrode lead port being configured to receive an electrode lead for stimulating a second cardiac region or detecting an electric signal at the second cardiac region, wherein the second cardiac region is a part of a ventricular conduction system of the heart, wherein the at least one electrode lead is intended to be implanted or is implanted in the second cardiac region; b) generating and releasing a notification signal if the second electrode lead configuration is selected.

Abstract: An implantable medical device for stimulating a human or animal heart, comprising a first processor, a first memory unit, a stimulation unit configured to stimulate a first cardiac region of a human or animal heart, and a detection unit configured to detect an electric signal at the first cardiac region of the same heart, wherein the detection unit comprises i) an electrode lead having an electrode pole and ii) a first channel for measuring electric signals provided by the electrode lead. A maximum sensitivity of the first channel of the detection unit is adjustable in dependence on a stimulation site of the electrode pole, wherein the maximum sensitivity of the first channel lies in a range of from 0.1 mV to 0.4 mV if the electrode pole is intended to detect electric signals at the His bundle of the heart.

Abstract: A cage can be positioned around a medical balloon, such as an angioplasty balloon, to assist in a medical procedure. The cage can include a plurality of strips, each extending between a set of rings including first and second rings. As the balloon expands, the first and second rings move closer together and allow the strips to expand outward. The cage may have wedge dissectors on the strips.

Abstract: A cage can be positioned around a medical balloon, such as an angioplasty balloon, to assist in a medical procedure. The cage can include a plurality of strips, each extending between a set of rings including first and second rings. As the balloon expands, the first and second rings move closer together and allow the strips to expand outward. The cage may have wedge dissectors on the strips.

Abstract: The invention relates to a device, a method, a computer program product and an application for establishing a current load level of a user. The device and the method comprise a mobile terminal, which comprises at least one sensor generating signal data and a plurality of available applications for use by the user and also an evaluation unit. According to the invention, provision is made for the mobile terminal to comprise an application, which is configured as further application and establishes a plurality of biometric data in respect of the user, at least from the signal data or from available applications used by the user, and to make said data available to the evaluation unit, and for the evaluation unit to determine the current load level of the user from the biometric data.

Abstract: The disclosure describes various aspects of a partial light field display architecture. In an aspect, a light field display includes multiple picture elements (e.g., super-raxels), where each picture element includes a first portion having a first set of light emitting elements, where the first portion is configured to produce light outputs that contribute to at least one a two-dimensional (2D) view. Each picture element also includes a second portion including a second set of light emitting elements (e.g., sub-raxels) configured to produce light outputs (e.g., ray elements) that contribute to at least one three-dimensional (3D) view. The light field display also includes electronic means configured to drive the first set of light emitting elements and the second set of light emitting elements in each picture element. The light field display can also dynamically identify the first portion and the second portion and allocate light emitting elements accordingly.

Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.